"Leukoplakia, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A white patch seen on the oral mucosa. It is considered a premalignant condition and is often tobacco-induced. When evidence of Epstein-Barr virus is present, the condition is called hairy leukoplakia (LEUKOPLAKIA, HAIRY).
- Leukoplakia, Oral
- Leukoplakias, Oral
- Oral Leukoplakia
- Oral Leukoplakias
- Leukokeratosis, Oral
- Leukokeratoses, Oral
- Oral Leukokeratoses
- Oral Leukokeratosis
- Keratosis, Oral
Below are MeSH descriptors whose meaning is more general than "Leukoplakia, Oral".
Below are MeSH descriptors whose meaning is more specific than "Leukoplakia, Oral".
This graph shows the total number of publications written about "Leukoplakia, Oral" by people in this website by year, and whether "Leukoplakia, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Leukoplakia, Oral" by people in Profiles.
Practice patterns for initial management of oral leukoplakia amongst otolaryngologists and oral and maxillofacial surgeons. Oral Oncol. 2023 04; 139:106341.
Proliferative Verrucous Leukoplakia: An Expert Consensus Guideline for Standardized Assessment and Reporting. Head Neck Pathol. 2021 Jun; 15(2):572-587.
Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study. J Natl Cancer Inst. 2020 10 01; 112(10):1047-1054.
Response to Brandt, Bednarz-Knoll, Kleinheinz et al. J Natl Cancer Inst. 2020 09 01; 112(9):970-971.
Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 06; 125(6):650-669.
Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer. J Natl Cancer Inst. 2018 03 01; 110(3).
Notch1 mutations are drivers of oral tumorigenesis. Cancer Prev Res (Phila). 2015 Apr; 8(4):277-286.
A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia. Oral Oncol. 2013 Sep; 49(9):970-976.